🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study adopts multicenter/randomized trial design. It plans to enroll p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-04-30
Trial ID
NCT06941142
Treatments Being Tested
A single 125 mg oral dose of the investigational compound PD-0332991 will b...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01821066
Treatments Being Tested
A study of palbociclib in combination with letrozole as treatment of post-m...
Status
Completed
Location
Benjamin Carl Forster
Start Date
2016-03-09
Trial ID
NCT02679755
Treatments Being Tested
POLAR is a phase III clinical trial, which will test the safety and efficac...
Status
Active Not Recruiting
Location
Medizinische Universität Graz (MUG)
Start Date
2019-08-27
Trial ID
NCT03820830
Treatments Being Tested
This is an open-label, dose-escalation and dose-expansion study to determin...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2022-07-05
Trial ID
NCT05238922
Treatments Being Tested
The primary objective of Phase 1b will be to evaluate the safety and tolera...
Status
Terminated
Location
Holy Cross Health Fort Lauderdale - Holy Cross Hospital
Start Date
2023-01-09
Trial ID
NCT05384119
Treatments Being Tested
to evaluate the effect of the PPI (rabeprazole) on the PK of a potential co...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2017-07-21
Trial ID
NCT03220191
Treatments Being Tested
This study will investigate whether concurrent administration of rabeprazol...
Status
Completed
Location
MRA Clinical Research - Phase 1
Start Date
2015-01
Trial ID
NCT02311946
Treatments Being Tested
This is a Phase 3, open-label, randomized, clinical trial evaluating the ef...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-12-08
Trial ID
NCT05501886
Treatments Being Tested
The trial consists of a series of parallel multi-centre single arm phase II...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2015-05-13
Trial ID
NCT02664935